Vimarsana
Biggest News Aggregation in the World

Hunterc Smith News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hunterc Smith. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hunterc Smith Today - Breaking & Trending Today

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Shares Sold by Primecap Management Co. CA - Vimarsana News

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Shares Sold by Primecap Management Co. CA

Primecap Management Co. CA reduced its position in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 2.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,052,648 shares of the company’s stock after selling 214,773 shares during the period. […]

Source: wkrb13.com
The Texas Chainsaw Massacre video game will be adding a new killer called Hands next month - Vimarsana News

The Texas Chainsaw Massacre video game will be adding a new killer called Hands next month

The Texas Chainsaw Massacre video game will be adding a new killer character called Hands into the mix next month

Source: joblo.com
Rhythm Pharmaceuticals' (RYTM) "Buy" Rating Reaffirmed at Needham & Company LLC - Vimarsana News

Rhythm Pharmaceuticals' (RYTM) "Buy" Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC reiterated their buy rating on shares of Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) in a research report released on Friday morning, Benzinga reports. They currently have a $50.00 target price on the stock. A number of other equities analysts also recently commented on RYTM. The Goldman Sachs Group upped their target […]

Rhythm Pharmaceuticals (NASDAQ:RYTM) PT Lowered to $52.00 at Wells Fargo & Company - Vimarsana News

Rhythm Pharmaceuticals (NASDAQ:RYTM) PT Lowered to $52.00 at Wells Fargo & Company

Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) had its target price lowered by Wells Fargo & Company from $53.00 to $52.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has an overweight rating on the stock. A number of other equities analysts have also recently weighed in on the stock. Needham & Company […]

Source: wkrb13.com
Profund Advisors LLC Sells 19,262 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Vimarsana News

Profund Advisors LLC Sells 19,262 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)

Profund Advisors LLC trimmed its holdings in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 40.9% in the 3rd quarter, Holdings Channel reports. The firm owned 27,818 shares of the company’s stock after selling 19,262 shares during the quarter. Profund Advisors LLC’s holdings in Rhythm Pharmaceuticals were worth $638,000 at the end of […]

Source: wkrb13.com